Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 16, 2014, Pages 5998-6003

  Pearce, Oliver M T ^a   Läubli, Heinz ^a   Verhagen, Andrea ^a   Secrest, Patrick ^a   Zhang, Jiquan ^b   Varki, Nissi M ^a   Crocker, Paul R ^b   Bui, Jack D ^c   Varki, Ajit ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibody dependent cellular cytotoxicity; M2 polarization; NK cells; Tumor associated macrophages

Indexed keywords

ANTIBODY; CD11B ANTIGEN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; N GLYCOLOYLNEURAMINIC ACID; POLYCLONAL ANTIBODY; RITUXIMAB; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SIZE; CONTROLLED STUDY; HORMESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INFLAMMATION; INNATE IMMUNITY; INVERSE HORMESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY; M2 POLARIZATION; NK CELLS; TUMOR-ASSOCIATED MACROPHAGES;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIBODY AFFINITY; BURKITT LYMPHOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HORMESIS; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS; NEURAMINIC ACIDS; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS;

EID: 84899096210     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1209067111     Document Type: Article

References (56)

1. Ehrlich P (1909) Ueber den jetzigen stand der Karzinomforschung. Ned Tijdschr Geneeskd 5:273. Dutch.
2. Burnet M (1957) Cancer: A biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. BMJ 1(5023):841-847.
3. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: From immunosurveillance to tumor escape. Nat Immunol 3(11):991-998.
4. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329-360.
5. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867.
6. Dinarello CA (2006) The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev 25(3):307-313.
7. Mantovani A, Romero P, Palucka AK, Marincola FM (2008) Tumour immunity: Effector response to tumour and role of the microenvironment. Lancet 371(9614):771-783.
8. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436-444.
9. zur Hausen H (2009) Papillomaviruses in the causation of human cancers - A brief historical account. Virology 384(2):260-265.
10. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883-899.
11. Elinav E, et al. (2013) Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13(11):759-771.
12. Rothwell PM, et al. (2011) Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials. Lancet 377(9759):31-41.
13. Bui JD, Schreiber RD (2007) Cancer immunosurveillance, immunoediting and inflammation: Independent or interdependent processes? Curr Opin Immunol 19(2):203-208.
14. Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 331(6024):1565-1570.
15. Pikarsky E, Ben-Neriah Y (2006) NF-kappaB inhibition: A double-edged sword in cancer? Eur J Cancer 42(6):779-784.
16. Naugler WE, et al. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317(5834):121-124.
17. Rakoff-Nahoum S, Medzhitov R (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317(5834):124-127.
18. Ghiringhelli F, et al. (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15(10): 1170-1178.
19. Zaidi MR, et al. (2011) Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature 469(7331):548-553.
20. Andreu P, et al. (2010) FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17(2):121-134.
21. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7(5):411-423.
22. Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y (2009) Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol 158(Suppl 1):43-50.
23. Bei R, Masuelli L, Palumbo C, Modesti M, Modesti A (2009) A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Cancer Lett 281(1):8-23.
24. De Palma M, Lewis CE (2013) Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23(3):277-286.
25. Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86(5):1065-1073.
26. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4):239-252.
27. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141(1):52-67.
28. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144(5):646-674.
29. Hedlund M, Padler-Karavani V, Varki NM, Varki A (2008) Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc Natl Acad Sci USA 105(48):18936-18941.
30. Padler-Karavani V, et al. (2011) Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res 71(9):3352-3363.
31. Prehn RT (1972) The immune reaction as a stimulator of tumor growth. Science 176(4031):170-171.
32. Andrews EJ (1971) Evidence of the nonimmune regression of chemically induced papillomas in mouse skin. J Natl Cancer Inst 47(3):653-665.
33. Prehn RT (2010) The initial immune reaction to a new tumor antigen is always stimulatory and probably necessary for the tumor's growth. Clin Dev Immunol 2010: 851728.
34. Tangvoranuntakul P, et al. (2003) Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA 100(21):12045-12050.
35. Calabrese EJ, Blain RB (2011) The hormesis database: The occurrence of hormetic dose responses in the toxicological literature. Regul Toxicol Pharmacol 61(1):73-81.
36. Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7(4):255-266.
37. Varki A, Crocker PR (2009) Essentials of Glycobiology, eds Varki A, et al. (Cold Spring Harbor Laboratory Press, Plainview, NY), pp 459-474.
38. Soto PC, Stein LL, Hurtado-Ziola N, Hedrick SM, Varki A (2010) Relative over-reactivity of human versus chimpanzee lymphocytes: Implications for the human diseases associated with immune activation. J Immunol 184(8):4185-4195.
39. Zhang JQ, Biedermann B, Nitschke L, Crocker PR (2004) The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur J Immunol 34(4):1175-1184.
40. McMillan SJ, et al. (2013) Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin- dependent signaling. Blood 121(11):2084-2094.
41. Van Rooijen N (1989) The liposome-mediated macrophage 'suicide ' technique. J Immunol Methods 124(1):1-6.
42. Hainsworth JD, et al. (2000) Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood 95(10):3052-3056.
43. Smyth MJ, Hayakawa Y, Takeda K, Yagita H (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2(11):850-861.
44. Willett WC (2000) Diet and cancer. Oncologist 5(5):393-404.
45. Larsson SC, Wolk A (2006) Meat consumption and risk of colorectal cancer: A metaanalysis of prospective studies. Int J Cancer 119(11):2657-2664.
46. Cho E, et al. (2006) Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 166(20):2253-2259.
47. Taylor EF, Burley VJ, Greenwood DC, Cade JE (2007) Meat consumption and risk of breast cancer in the UK Women's Cohort Study. Br J Cancer 96(7):1139-1146.
48. Linos E, Willett WC, Cho E, Colditz G, Frazier LA (2008) Red meat consumption during adolescence among premenopausal women and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 17(8):2146-2151.
49. Wallace K, et al. (2009) The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 18(8):2310-2317.
50. Lam TK, et al. (2009) Intakes of red meat, processed meat, and meat mutagens increase lung cancer risk. Cancer Res 69(3):932-939.
51. Tasevska N, et al. (2009) A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 89(6):1884-1894.
52. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A (2009) Meat intake and mortality: A prospective study of over half a million people. Arch Intern Med 169(6): 562-571.
53. Ferrucci LM, et al. (2009) Dietary meat intake in relation to colorectal adenoma in asymptomatic women. Am J Gastroenterol 104(5):1231-1240.
54. Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357(9255):539-545.
55. Seibold HR, Wolf RH (1973) Neoplasms and proliferative lesions in 1065 nonhuman primate necropsies. Lab Anim Sci 23(4):533-539.
56. Varki NM, Strobert E, Dick EJ, Jr., Benirschke K, Varki A (2011) Biomedical differences between human and nonhuman hominids: Potential roles for uniquely human aspects of sialic acid biology. Annu Rev Pathol 6:365-393.